By inhibiting the PD-1/PD-L1 axis and chemokine secretion (Ji et al., 2024), these extracts restore CD8+T cell function and enhance immune surveillance, thereby modulating the tumor microenvironment. The gene discussed is CD274; the disease is neoplasm.